Logo image of AAMC

ALTISOURCE ASSET MANAGEMENT (AAMC) Stock Fundamental Analysis

USA - NYSEARCA:AAMC - VI02153X1080 - Common Stock

1.25 USD
-0.06 (-4.59%)
Last: 9/16/2024, 8:04:00 PM
1.28 USD
+0.03 (+2.4%)
After Hours: 9/16/2024, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, AAMC scores 2 out of 10 in our fundamental rating. AAMC was compared to 64 industry peers in the Real Estate Management & Development industry. AAMC may be in some trouble as it scores bad on both profitability and health. AAMC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AAMC had positive earnings in the past year.
In the past year AAMC has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AAMC reported negative net income in multiple years.
AAMC had negative operating cash flow in 4 of the past 5 years.
AAMC Yearly Net Income VS EBIT VS OCF VS FCFAAMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of 488.17%, AAMC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
AAMC has a Return On Equity of 3054.88%. This is amongst the best in the industry. AAMC outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 488.17%
ROE 3054.88%
ROIC N/A
ROA(3y)-12%
ROA(5y)-0.28%
ROE(3y)-28.5%
ROE(5y)-8.89%
ROIC(3y)N/A
ROIC(5y)N/A
AAMC Yearly ROA, ROE, ROICAAMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

1.3 Margins

The Profit Margin of AAMC (-744.02%) is better than 64.18% of its industry peers.
The Operating Margin and Gross Margin are not available for AAMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) -744.02%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAMC Yearly Profit, Operating, Gross MarginsAAMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

3

2. Health

2.1 Basic Checks

AAMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
AAMC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for AAMC has been reduced compared to 5 years ago.
There is no outstanding debt for AAMC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AAMC Yearly Shares OutstandingAAMC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
AAMC Yearly Total Debt VS Total AssetsAAMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -4.51, we must say that AAMC is in the distress zone and has some risk of bankruptcy.
AAMC has a worse Altman-Z score (-4.51) than 89.55% of its industry peers.
AAMC has a Debt/Equity ratio of 3.45. This is a high value indicating a heavy dependency on external financing.
AAMC's Debt to Equity ratio of 3.45 is on the low side compared to the rest of the industry. AAMC is outperformed by 82.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Altman-Z -4.51
ROIC/WACCN/A
WACC9.82%
AAMC Yearly LT Debt VS Equity VS FCFAAMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

AAMC has a Current Ratio of 1.32. This is a normal value and indicates that AAMC is financially healthy and should not expect problems in meeting its short term obligations.
AAMC has a Current ratio of 1.32. This is comparable to the rest of the industry: AAMC outperforms 49.25% of its industry peers.
AAMC has a Quick Ratio of 1.32. This is a normal value and indicates that AAMC is financially healthy and should not expect problems in meeting its short term obligations.
AAMC has a Quick ratio of 1.32. This is comparable to the rest of the industry: AAMC outperforms 53.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
AAMC Yearly Current Assets VS Current LiabilitesAAMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

AAMC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 955.92%, which is quite impressive.
The Revenue for AAMC has decreased by -296.72% in the past year. This is quite bad
EPS 1Y (TTM)955.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5148.57%
Revenue 1Y (TTM)-296.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-87.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAMC Yearly Revenue VS EstimatesAAMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2022 2023 0 100M 200M 300M 400M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.03, which indicates a rather cheap valuation of AAMC.
Based on the Price/Earnings ratio, AAMC is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
AAMC is valuated cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.03
Fwd PE N/A
AAMC Price Earnings VS Forward Price EarningsAAMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAMC Per share dataAAMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AAMC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTISOURCE ASSET MANAGEMENT

NYSEARCA:AAMC (9/16/2024, 8:04:00 PM)

After market: 1.28 +0.03 (+2.4%)

1.25

-0.06 (-4.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-08 2024-08-08/amc
Earnings (Next)11-12 2024-11-12/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners52.42%
Ins Owner Change0%
Market Cap3.19M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.03
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)41.51
EY3320.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.69
FCFYN/A
OCF(TTM)-2.7
OCFYN/A
SpS-5.25
BVpS1.28
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 488.17%
ROE 3054.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -744.02%
GM N/A
FCFM N/A
ROA(3y)-12%
ROA(5y)-0.28%
ROE(3y)-28.5%
ROE(5y)-8.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.66
Health
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.93%
Cap/Sales -0.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z -4.51
F-Score5
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)313.67%
Cap/Depr(5y)208.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)955.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5148.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-296.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-87.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-249.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.27%
OCF growth 3YN/A
OCF growth 5YN/A